图书馆主页
数据库简介
最新动态
联系我们



返回首页


 刊名字顺( Alphabetical List of Journals):

  A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL


  检 索:         高级检索

期刊名称:MEDICAL LETTER ON DRUGS AND THERAPEUTICS

ISSN:0025-732X
出版频率:Biweekly
出版社:MED LETTER INC, 1000 MAIN STREET, NEW ROCHELLE, NY, 10801
  出版社网址:http://www.medletter.com/
期刊网址:http://www.medletter.com/
影响因子:0.393(2008)
主题范畴:PHARMACOLOGY & PHARMACY

期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)   



About the journal

 The Medical Letter on Drugs and Therapeutics

The Medical Letter is a nonprofit organization founded in 1958 by Arthur Kallet, the co-founder and former director of Consumers Union, and Dr. Harold Aaron, a former medical advisor to Consumers Union.

Its newsletters, The Medical Letter on Drugs and Therapeutics and Treatment Guidelines from The Medical Letter, publish critical appraisals of new drugs and comparative reviews of older drugs. The editorial process used for both publications relies on a consensus of experts to develop prescribing recommendations that are completely independent of the pharmaceutical industry. The Medical Letter and Treatment Guidelines are, therefore, crucial resources for members of the health care community to consult when confronted by the advertisements and sales representatives of the industry.

 


Instructions to Authors

 

An expert consultant or one of our editors prepares a preliminary report on the drug (for The Medical Letter) or drugs for particular indications (for Treatment Guidelines) in terms of their effectiveness, adverse effects and possible alternatives. Both published and available unpublished studies are carefully examined, paying special attention to the results of controlled clinical trials.

The preliminary draft is edited and sent to every member of the Advisory Board of The Medical Letter, to 10 to 20 other investigators who have special clinical and experimental experience with the drug, type of drug or disease under review, to appropriate representatives of the pharmaceutical companies making the drugs, and sometimes to companies that make competitive drugs as well.

Many criticisms, suggestions and questions come in from the reviewers in letters, faxes, e-mail and telephone calls. Further extended communication as needed is followed by final checking and editing to make the appraisal not only accurate, but also easy to read.


Editorial Board

 

EDITOR Mark Abramowicz, M.D.
DEPUTY EDITOR

Gianna Zuccotti, M.D., M.P.H.
Weill Medical College of Cornell University

CONSULTING EDITOR Martin A. Rizack, M.D. Ph.D.
The Rockefeller University
CONTRIBUTING EDITORS Philip D. Hansten, Pharm. D.
University of Washington
Neal H. Steigbigel, M.D.
New York University School of Medicine
ASSOCIATE EDITORS Donna Goodstein
Amy Faucard
MANAGING EDITOR Susie Wong
ADVISORY BOARD Jules Hirsch, M.D.
The Rockefeller University
James D. Kenney, M.D.
Yale University School of Medicine
Gerald L. Mandell, M.D.
University of Virginia School of Medicine
Hans Meinertz, M.D.
University Hospital, Copenhagen
Dan M. Roden, M.D.
Vanderbilt School of Medicine
F. Estelle R. Simons, M.D.
University of Manitoba
EDITORIAL FELLOWS
Elizabeth Stephens, M.D.
Oregon Health Sciences University School of Medicine
Arthur M.F. Yee, M.D., Ph.D.
Cornell University Medical Center



 返回页首 


邮编:430072   地址:中国武汉珞珈山   电话:027-87682740   管理员Email:
Copyright © 2005-2006 武汉大学图书馆版权所有